Company

Perspective Therapeutics, Inc.

Follow Open structure map Ask about this Research this company

Structure of Perspective Therapeutics, Inc.

Perspective Therapeutics, Inc.

Company

4 connections

UpstreamSupply and dependency

OwnProducts and technology

Relationship began2026

Perspective Therapeutics, Inc.Company · 4 connections

Layer 1

UpstreamSupply and dependency3

OwnProducts and technology1

Relations

Arrows show the direction of the relationship. Filter to focus on a business area.

Perspective Therapeutics, Inc.uses →Lead-212 (²¹²Pb)
Material · Lead-212 (²¹²Pb)Evidence 1
Fact90%
View evidence
- CompanyGlobeNewswire public company news2026-10-07 18:16
 The Company has proprietary technology that utilizes the alpha-generating isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
 View source
Perspective Therapeutics, Inc.uses →Lead-212
Material · Lead-212Evidence 1
Fact90%
View evidence
- CompanyGlobeNewswire public company news2026-10-08 18:16
 The Company has proprietary technology that utilizes the alpha-generating isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
 View source
Perspective Therapeutics, Inc.manufactures →Clinical drug product candidates
Product · Clinical drug product candidatesEvidence 1
Fact90%
View evidence
- CompanyGlobeNewswire public company news2026-10-08 18:16
 its proprietary 224Ra/212Pb generator platform used to manufacture clinical drug product candidates
 View source
Perspective Therapeutics, Inc.uses →Radium-224/Lead-212 generator platform
Technology · Radium-224/Lead-212 generator platformEvidence 1
Fact90%
View evidence
- CompanyGlobeNewswire public company news2026-10-08 18:16
 its proprietary 224Ra/212Pb generator platform used to manufacture clinical drug product candidates
 View source

Showing 1 to 4 of 4

Claims

Read the assertion alongside its sources. Expand a row to inspect the evidence.

FactEvidence 1

usesLead-212

The Company has proprietary technology that utilizes the alpha-generating isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

GlobeNewswire public company news · 2026-10-08 18:16

View evidence

CompanyGlobeNewswire public company news2026-10-08 18:16
The Company has proprietary technology that utilizes the alpha-generating isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
View source

FactEvidence 1

manufacturesClinical drug product candidates

its proprietary 224Ra/212Pb generator platform used to manufacture clinical drug product candidates

GlobeNewswire public company news · 2026-10-08 18:16

View evidence

CompanyGlobeNewswire public company news2026-10-08 18:16
its proprietary 224Ra/212Pb generator platform used to manufacture clinical drug product candidates
View source

FactEvidence 1

usesRadium-224/Lead-212 generator platform

its proprietary 224Ra/212Pb generator platform used to manufacture clinical drug product candidates

GlobeNewswire public company news · 2026-10-08 18:16

View evidence

CompanyGlobeNewswire public company news2026-10-08 18:16
its proprietary 224Ra/212Pb generator platform used to manufacture clinical drug product candidates
View source

FactEvidence 1

usesLead-212 (²¹²Pb)

The Company has proprietary technology that utilizes the alpha-generating isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

GlobeNewswire public company news · 2026-10-07 18:16

View evidence

CompanyGlobeNewswire public company news2026-10-07 18:16
The Company has proprietary technology that utilizes the alpha-generating isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
View source

Showing 1 to 4 of 4

Market and valuation

Valuation data is available on Pro and Research.

Included in Pro

Not available: Company signals · Financials · Filings · Guidance